Plain-English translation of NCT06663332 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This is a long-term safety study of , a medication that helps reduce inflammation in children with Crohn's disease, ulcerative colitis, or juvenile psoriatic arthritis. Children who already tried this medication in earlier clinical trials and felt better can continue receiving it in this study to help doctors understand how safe it is over time.
Doctors need to know if this treatment remains safe and effective when children take it for many months or years. This study gives kids who benefited from the medication a chance to keep using it while providing important long-term safety information.
You likely qualify if…
You likely don't qualify if…
You will continue receiving injections of the medication under your skin, either every 4 weeks or every 8 weeks depending on your doctor's recommendation and how you're responding. You'll have regular visits with the study team to check how you're doing, discuss any side effects, and make sure the medication is working well for you. The study continues as long as you and your doctor agree the medication is helping and it remains safe.
AI-generated summary from trial data · Sep 1, 2026 · Not medical advice
United States